Cargando…

P17-02. PolyCTLDesigner: the software for constructing highly efficient polyepitope immunogens. Application to HIV-1

Detalles Bibliográficos
Autores principales:	Antonets, D, Maksyutov, A, Bazhan, S
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767786/ http://dx.doi.org/10.1186/1742-4690-6-S3-P284

Ejemplares similares

PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens
por: Antonets, Denis V, et al.
Publicado: (2013)

Design and Evaluation of Optimized Artificial HIV-1 Poly-T Cell-Epitope Immunogens
por: Reguzova, Alena, et al.
Publicado: (2015)

Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV‐1 polyepitope CTL immunogen
por: Karpenko, Larisa I., et al.
Publicado: (2012)

PA02.17. Viruddha Aahara– Trisutra
por: Dunghav, Manisha
Publicado: (2013)

P19-17. Construction of HIV-1 AE subtype gp140 DNA vaccine and immunogenicity evaluation
por: Zhang, C, et al.
Publicado: (2009)

Immunogenicity evaluation of the HIV-1 Tat containing polyepitope DNA vaccine adjuvanted with CpG-ODNs in mice
por: Ollah Jazaeri, Ehsan, et al.
Publicado: (2021)

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant
por: Sun, J, et al.
Publicado: (2009)

The development of Chinese specific human cytomegalovirus polyepitope recombinant vaccine
por: Zhao, Ping, et al.
Publicado: (2012)

P05.02. Constructing an integrative medicine care service in a Brazilian University hospital
por: Siegel, P, et al.
Publicado: (2012)

In silico Designed Ebola Virus T-Cell Multi-Epitope DNA Vaccine Constructions Are Immunogenic in Mice
por: Bazhan, Sergei I., et al.
Publicado: (2019)

P02-01. Elicitation of a humoral immune response towards non-immunogenic peptides using the transcriptional transactivator of HIV-1
por: Gadzinski, A, et al.
Publicado: (2009)

P02.17. Building a database of validated pediatric outcomes: an investigation of compliance with established reporting standards
por: Adams, D, et al.
Publicado: (2012)

P17-15. Immunogenicity studies of chimeric yellow fever 17D viruses carrying HIV-1 p24 antigen
por: Franco, D, et al.
Publicado: (2009)

Efficiency of ventilators for intermediate care to deliver adequate FI02. a bench study
por: Baboi, L, et al.
Publicado: (2015)

TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer Therapy
por: Bei, Roberto, et al.
Publicado: (2010)

P17. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells
por: Schnurr, M, et al.
Publicado: (2014)

P02-12. Bupivacaine, a local anaesthetic, enhances immunogenicity of a multiepitopic DNA vaccine containing HIV promiscuous CD4 T cell epitopes
por: Rosa, DS, et al.
Publicado: (2009)

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)
por: Gil, C, et al.
Publicado: (2009)

PA02.02. A comprehensive review of “Vaidya Vinoda” manuscript with reference to formulations and pharmaceutical procedures
por: Vyas, Ramakant
Publicado: (2013)

P02.37. Mindfulness for caregivers
por: Bloom, P, et al.
Publicado: (2012)

P02.184. Abstract withdrawn
Publicado: (2012)

P02-17 Promoting physical activity for mental health in the EU: Development and implementation of practice guidelines from the SPHERE EU project 2019-2020
por: Crone, Diane, et al.
Publicado: (2022)

P19-04. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins
por: Ilyichev, A, et al.
Publicado: (2009)

P02-02 Evaluating community-based programmes for health promotion: a novel approach considering the complexity perspective
por: Huiberts, Irma, et al.
Publicado: (2022)

The use of V02 and VC02 to optimise respiratory support and to wean mechanically ventilated patients after major abdominal surgery
por: Petrova, MV, et al.
Publicado: (2015)

Fusion of CTA and CTB gene to immunogen significantly enhances the immunogenicity of DNA vaccine
por: Ren, X, et al.
Publicado: (2012)

Design and expression of fusion protein consists of HBsAg and Polyepitope of HCV as an HCV potential vaccine
por: Gholizadeh, Monireh, et al.
Publicado: (2015)

P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens
por: Reddy, S Mohana Rama, et al.
Publicado: (2009)

Construction and characterization of neutralizing antibody fragments for efficient access to V3 epitope
por: Maruta, Y
Publicado: (2012)

P02.168. Safety issues and orthorexia in paediatrics
por: von Rosenstiel, I, et al.
Publicado: (2012)

P02.66. Efficacy of acupuncture for fibromyalgia - RCT
por: Vinjamury, S, et al.
Publicado: (2012)

P02.160. The psychosomatic model for clinical oncology
por: Zhirkov, A, et al.
Publicado: (2012)

Anti-HIV and immune modulating activities of IND02
por: Biedma, ME, et al.
Publicado: (2012)

PA02.08. Role of herbs in psychosomatic disorders
por: Ramgopal, KVRSS
Publicado: (2013)

PA02.11. An insight on ayurvedic drug discovery
por: Desai, Yogesh
Publicado: (2013)

PA02.12. Toxicity studies on shankha vati
por: Kodlady, Naveena, et al.
Publicado: (2013)

PA02.21. Stability study in ayurvedic products
por: Neeraj, PT, et al.
Publicado: (2013)

P02-02. Analysis of antigen specific degranulation potentials using IL-12 or IL-28B during HIV DNA Vaccination
por: Morrow, M, et al.
Publicado: (2009)

Relationship between transcutaneous C02 measurement and PAC02 during non invasive ventilation delivered because of hypercapnic acute respiratory failure
por: Thévoz, D, et al.
Publicado: (2015)

P02.49. Dynamical system approach for CAM research
por: Ahn, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_14k8s6jh0alt5d7k45i3bjmnf2